Prosecution Insights
Prosecution Insights
13 pending office actions • 7 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 2 (15%) |
| §102 only | 1 (8%) |
| §112 only | 2 (15%) |
| Double-patenting only | 3 (23%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 3 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GILL, RACHEL B | 1 | 65.4% | +28.0% |
| SINGH, ANOOP KUMAR | 1 | 42.8% | +67.4% |
| LEONARD, ARTHUR S | 1 | 50.9% | +50.5% |
| VANHORN, ABIGAIL LOUISE | 1 | 47.0% | +22.0% |
| CORDAS, EMILY ANN | 1 | 50.4% | +58.1% |
| ARON, KIMBERLY A | 1 | 54.7% | +34.9% |
| BATES, KEENAN ALEXANDER | 1 | 44.8% | +76.5% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| CHONG, YONG SOO | 1 | 43.7% | +41.7% |
| KIM, TAEYOON | 1 | 51.6% | +51.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | KIM, TAEYOON | 147d overdue |
| 17637058 | COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING | LIPPOLIS, ALEXANDRA ROSE | 125d overdue |
| 18016251 | SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 | BATES, KEENAN ALEXANDER | 9d |
| 17104372 | TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA | RAVINDRA, KRISHNA NUGGEHALLI | 34d |
| 18151093 | RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION | BRETZ, COREY LANE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | KIM, TAEYOON | 147d overdue |
| 18028751 | PATIENT SELECTION BIOMARKERS FOR TREATMENT WITH ULK INHIBITORS | VANHORN, ABIGAIL LOUISE | 19d overdue |
| 18426803 | SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS | SINGH, ANOOP KUMAR | 7d |
| 18297323 | MOTOR NEURON-SPECIFIC EXPRESSION VECTORS | ARON, KIMBERLY A | 7d |
| 18016251 | SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 | BATES, KEENAN ALEXANDER | 9d |
| 18133237 | MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE | CORDAS, EMILY ANN | 15d |
| 18797069 | HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDENT CANCERS | GILL, RACHEL B | — |
| 18302962 | SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF | LEONARD, ARTHUR S | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1632 | 2 |
| 1636 | 2 |
| 1633 | 2 |
| 1635 | 1 |
| 1623 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18797069 | HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDENT CANCERS | GILL, RACHEL B | — | DP | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18426803 | SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS | SINGH, ANOOP KUMAR | 1632 | §112Other | Non-Final OA | 7d | Pending | Jan 30, 2024 |
| 18302962 | SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF | LEONARD, ARTHUR S | 1631 | §112 | Final Rejection | — | Pending | Apr 19, 2023 |
| 18028751 | PATIENT SELECTION BIOMARKERS FOR TREATMENT WITH ULK INHIBITORS | VANHORN, ABIGAIL LOUISE | 1636 | DP | Final Rejection | 19d overdue | Pending | Apr 12, 2023 |
| 18133237 | MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE | CORDAS, EMILY ANN | 1632 | §103 | Final Rejection | 15d | Pending | Apr 11, 2023 |
| 18297323 | MOTOR NEURON-SPECIFIC EXPRESSION VECTORS | ARON, KIMBERLY A | 1633 | §103Other | Non-Final OA | 7d | Pending | Apr 07, 2023 |
| 18016251 | SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 | BATES, KEENAN ALEXANDER | 1631 | §102§103Other | Non-Final OA | 9d | Pending | Jan 13, 2023 |
| 18151093 | RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION | BRETZ, COREY LANE | 1635 | §102§103§112DP | Non-Final OA | — | Pending | Jan 06, 2023 |
| 17990489 | FLAVONE DERIVATIVES AND USES IN TARGETING CK2-MEDIATED DISEASES AND CONDITIONS | CHONG, YONG SOO | 1623 | §102Other | Final Rejection | — | Pending | Nov 18, 2022 |
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | KIM, TAEYOON | 1631 | §102§103 | Final Rejection | 147d overdue | Pending | Apr 15, 2022 |
| 17681538 | ADENOVIRAL ASSEMBLY METHOD | PRONZATI, GINA | 1633 | DP | Final Rejection | — | Pending | Feb 25, 2022 |
| 17637058 | COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING | LIPPOLIS, ALEXANDRA ROSE | 1637 | §101§102§103 | Final Rejection | 125d overdue | Pending | Feb 21, 2022 |
| 17104372 | TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | §103§112 | Final Rejection | 34d | Pending | Nov 25, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial